Stockholders’ Deficit (Tables)

3 Months Ended

Apr. 30, 2024

Equity [Abstract]

Schedule of Stock Options Roll Forward

A summary of the stock option activity and related information is as follows:

	Number of Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2024	3,185,020	$	6.23	4.2	$	71,347
Granted	8,000,000	32.00
Exercised	(641,537)	5.64			16,455
Cancelled	(1,500)	7.99
Outstanding as of April 30, 2024	10,541,983	25.82		8.5	65,344
Vested and exercisable as of April 30, 2024	2,429,487	$	5.76	3.8	$	63,805

Schedule of Nonvested Performance-Based Units Activity

Tranche	Target Stock Value	Number of Stock Options Eligible to Vest	Option Valuation Expiration Date
1	$42.88	666,667	Fifth anniversary of the Company's IPO
2	$53.76	666,667
3	$64.64	666,667
4	$75.52	666,667
5	$86.40	666,667	Seventh anniversary of the Company's IPO
6	$96.96	666,667
7	$107.84	666,667
8	$118.72	666,667
9	$161.92	1,333,332
10	$242.88	1,333,332

Schedule of Nonvested Restricted Stock Units Activity

A summary of the RSU activity and related information is as follows:

	Number of RSUs	Weighted-Average Grant Date Fair Value
Outstanding as of January 31, 2024	50,191,670	$	16.09
Granted	9,383,173	30.64
Vested	(29,862,673)	13.25
Forfeited	(605,129)	21.38
Unvested as of April 30, 2024	29,107,041	$	23.89
Vested and not yet released	50	10.10
Outstanding as of April 30, 2024	29,107,091	$	23.89

Stock-Based Compensation Expense

Total stock-based compensation expense included in the Company’s consolidated statements of operations was as follows (in thousands):

	Three Months Ended April 30,
	2024		2023
Cost of revenue
Subscription	$	35,193	$	2
Maintenance	2,459		—
Other	11,247		3
Research and development	224,149		167
Sales and marketing	239,888		199
General and administrative	117,394		57
Total stock-based compensation expense	$	630,330	$	428